Arvee Laboratories Complete Financial Statements
In FY2026, Arvee Laboratories (ARVEE) reported revenue ₹32 Cr, net profit ₹2 Cr and EPS ₹2.29, with a net profit margin of 6.3% and ROE of 5.9%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review ARVEE price earnings ratio to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
ARVEE Revenue, Net Profit & EBITDA — Year-on-Year Growth
ARVEE YoY (March 2025 vs March 2026) — revenue -17.9%, EBITDA -25.0%, expenses -20.0%. Explore Arvee Laboratories intrinsic price to estimate fundamental worth using multiple valuation models.
ARVEE Income Statement — Revenue, EBITDA & Net Profit
Arvee Laboratories revenue ₹32 Cr, EBITDA ₹3 Cr, net profit ₹2 Cr, EPS ₹2.29 (2026) — net profit margin 6.3%. For live price, earnings ratios and company overview, see ARVEE share price.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32 | 39 | 31 | 63 | 41 | 48 | 46 | 55 | 48 | 35 |
| Expenses | 28 | 35 | 27 | 54 | 35 | 41 | 39 | 49 | 41 | 29 |
| EBITDA | 3 | 4 | 4 | 9 | 6 | 7 | 6 | 7 | 7 | 6 |
| Operating Profit Margin % | 10.00% | 9.00% | 10.00% | 12.00% | 14.00% | 13.00% | 13.00% | 11.00% | 15.00% | 17.00% |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 4 |
| Profit Before Tax | 2 | 3 | 2 | 6 | 3 | 4 | 3 | 3 | 2 | 1 |
| Tax | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | -1 |
| Net Profit | 2 | 2 | 1 | 4 | 3 | 3 | 2 | 2 | 1 | 2 |
| Earnings Per Share (₹) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | 4.17 | 4.11 | 2.58 | 3.83 |
ARVEE Balance Sheet — Assets, Liabilities & Shareholders' Equity
ARVEE total assets ₹43 Cr, total equity ₹34 Cr, total liabilities ₹ Cr (2026) — ROE 5.9%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Total Assets | 43 | 38 | 38 | 39 | 39 | 41 | 34 | 37 | 44 | 36 |
| Current Assets | 25 | 20 | 17 | 22 | 24 | 26 | 18 | 21 | 27 | 19 |
| Fixed Assets | 18 | 15 | 13 | 13 | 14 | 14 | 13 | 13 | 15 | 17 |
| Capital Work in Progress | 1 | 1 | 3 | 2 | 1 | 1 | 2 | 2 | 1 | 0 |
| Investments | 9 | 0 | 0 | 0 | 0 | 2 | 3 | 2 | 0 | 0 |
| Other Assets | 0 | 22 | 23 | 25 | 24 | 24 | 16 | 20 | 28 | 19 |
| LIABILITIES | ||||||||||
| Total Liabilities | ||||||||||
| Current Liabilities | 2 | 3 | 2 | 2 | 1 | 1 | 2 | 4 | 9 | 17 |
| Non-Current Liabilities | ||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||
| Total Equity | 34 | 31 | 29 | 28 | 24 | 21 | 19 | 17 | 14 | 4 |
| Share Capital | 11 | 11 | 11 | 11 | 11 | 11 | 6 | 6 | 6 | 4 |
| Reserves & Surplus | 23 | 20 | 18 | 17 | 13 | 10 | 13 | 11 | 9 | 0 |
ARVEE Cash Flow Statement — Operating, Investing & Financing
Arvee Laboratories operating cash flow ₹0 Cr, investing ₹-1 Cr, financing ₹0 Cr, net cash flow ₹-2 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 4 | 3 | 1 | 2 | 10 | 10 | 6 | 4 | 6 | 9 |
| Investing Activities | -1 | -2 | -1 | 0 | -1 | -3 | -3 | -1 | -1 | -5 | -6 |
| Financing Activities | 0 | 0 | -2 | -6 | 5 | -10 | -5 | -4 | -3 | -1 | -2 |
| Net Cash Flow | -2 | 1 | -1 | -5 | 6 | -3 | 2 | 1 | 0 | 0 | 1 |